Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization
about
Anti-Group A Streptococcal Vaccine Epitope: STRUCTURE, STABILITY, AND ITS ABILITY TO INTERACT WITH HLA CLASS II MOLECULESPathogenesis of group A streptococcal infectionsAnchor structure of staphylococcal surface proteins. II. Cooh-terminal structure of muramidase and amidase-solubilized surface protein.Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.Surface display of recombinant proteins on Bacillus subtilis spores.Study of humoral immunity to commensal oral bacteria in human infants demonstrates the presence of secretory immunoglobulin A antibodies reactive with Actinomyces naeslundii genospecies 1 and 2 ribotypes.Use of luciferase genes as biosensors to study bacterial physiology in the digestive tractMucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine.Sortase-catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus.Novel Sample Preparation for Mass Spectral Analysis of Complex Biological Samples.Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii.Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii.Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae.Purification and immunogenicity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordonii.Erysipelothrix rhusiopathiae YS-1 as a live vaccine vehicle for heterologous protein expression and intranasal immunization of pigs.Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci.Biotechnological approaches to fight pathogens at mucosal sites.Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody.Live bacterial vaccines--a review and identification of potential hazards.Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants.Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA.Advances in the development of bacterial vector technology.Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria.Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells.The Application of Magnetic Bead Selection to Investigate Interactions between the Oral Microbiota and Salivary ImmunoglobulinsExpression of a functional single-chain variable-fragment antibody against complement receptor 1 in Streptococcus gordonii.Engineering of a human vaginal Lactobacillus strain for surface expression of two-domain CD4 moleculesPrimary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria.Expression and immunogenicity of a recombinant diphtheria toxin fragment A in Streptococcus gordonii.Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against Salmonella Typhimurium and Salmonella Enteritidis.Expression of functional Porphyromonas gingivalis fimbrillin polypeptide domains on the surface of Streptococcus gordonii.Intracellular delivery of HA1 subunit antigen through attenuated Salmonella Gallinarum act as a bivalent vaccine against fowl typhoid and low pathogenic H5N3 virusLactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts.Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14.Streptococcus gordonii strains resistant to fluorodeoxyuridine contain mutations in the thymidine kinase gene and are deficient in thymidine kinase activity.Recombinant Staphylococcus strains as live vectors for the induction of neutralizing anti-diphtheria toxin antisera.Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii.Oral immunization with recombinant Streptococcus gordonii expressing porphyromonas gingivalis FimA domainsAnalysis of factors affecting surface expression and immunogenicity of recombinant proteins expressed by gram-positive commensal vectors.
P2860
Q27666345-64E675D8-220A-4A84-8860-C50C0B7951CAQ29615547-A1D914B0-B486-4524-A126-A077C2EEBED3Q31993447-C1AFAD54-197C-4C7C-9188-41245902F28DQ33538951-47306068-3261-47B2-9CAC-C33B8D0A7676Q33554407-366E7C10-8749-43E1-8A2F-266287A57631Q33711995-7C449B77-4A66-4DC4-9273-6105AC0B7D92Q33715490-EE557A67-1491-46F5-8B32-C0C2C166049AQ33756245-D857449D-202B-4112-A1E5-8DE7430F1FA4Q33950921-0002DD1D-84E4-4D77-A79B-9747C8FDE2C8Q33952033-C9451C7B-7660-425B-819A-1673E7DDCEC1Q34000750-71898D3D-389E-4F72-9844-A7B445730327Q34003291-8B305558-2143-42CF-BB1E-A6D3877F3437Q34006511-7A86BE66-BE84-4910-AA10-67005819E372Q34059015-C2375D22-D4E5-48EB-BBB1-37774B53A7A1Q34115654-2D571B88-2D28-4466-8E20-8E5BC7BC6A3BQ34145098-10782B76-69DB-4F07-8BE9-E3F283E8C12AQ34260712-62F0E37A-688F-4DE5-9B99-DF267EBFD6DBQ34351883-EE4DB99D-C89E-4A00-8A79-A1EC78CA0627Q34552312-D6490BDF-1877-4F9B-92C3-3FA00F5B0D92Q34974711-55682F9A-8CDA-46C4-BB30-BCBBFDC5D268Q35042482-9A656B23-940E-4777-93C1-DBB909422E83Q35066276-9B6421ED-ADA9-4FC1-BA9A-6A4EB73CCB48Q35193532-C81B8AD7-7981-4F60-B06F-5A98EBCFCA60Q35623001-344C99B8-F917-43BA-9663-1A100263B919Q36066835-4208A337-2FB7-4818-9C2A-51133579AC9BQ36092448-7B5865D4-5452-4358-BB21-8A993132F484Q36746887-893E23B7-8987-4B9F-B62B-AFCAD49CA43FQ36824239-F56481AC-B852-445F-A0D6-3C4D091DCF64Q36974497-806B0980-2205-4EB1-82BB-A700E49295DAQ37044911-4DC93FEB-E374-4574-9A32-E475675D5F04Q37667270-5AB5DA94-5D5E-42A3-A56E-C3A2E7409001Q38351982-8D944DCB-EA7A-4F5D-AF5F-7311739BD5BBQ38636511-FABBADCA-AEF4-43AC-8302-F650EAEC6B57Q39179768-EB28979E-0741-4954-BE84-2D0E6506D1BDQ39183855-1DA08407-7022-4686-846B-4EF0706DEE10Q39473307-5FE9AA4D-EA27-413A-BABB-A8707C342A47Q39512161-9A108D4C-7183-443D-8C8C-FD27813BCDB4Q39514978-CCFA9C86-48B7-4D7B-B2A8-EC47B0AE8F6CQ39519776-0CE04287-E5C0-41D9-98DF-8567C10E6DDFQ39654898-8C26742C-6510-491A-8439-5D9647662B1A
P2860
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Mucosal and systemic immune re ...... rdonii after oral colonization
@ast
Mucosal and systemic immune re ...... rdonii after oral colonization
@en
Mucosal and systemic immune re ...... rdonii after oral colonization
@nl
type
label
Mucosal and systemic immune re ...... rdonii after oral colonization
@ast
Mucosal and systemic immune re ...... rdonii after oral colonization
@en
Mucosal and systemic immune re ...... rdonii after oral colonization
@nl
prefLabel
Mucosal and systemic immune re ...... rdonii after oral colonization
@ast
Mucosal and systemic immune re ...... rdonii after oral colonization
@en
Mucosal and systemic immune re ...... rdonii after oral colonization
@nl
P2860
P356
P1476
Mucosal and systemic immune re ...... rdonii after oral colonization
@en
P2093
V A Fischetti
P2860
P304
P356
10.1073/PNAS.92.15.6868
P407
P577
1995-07-01T00:00:00Z